Enhabit, Inc. (EHAB)

Market Cap	384.67M
Revenue (ttm)	1.04B
Net Income (ttm)	-116.60M
Shares Out	50.28M
EPS (ttm)	-2.33
PE Ratio	n/a
Forward PE	32.04
Dividend	n/a
Ex-Dividend Date	n/a

Volume	341,158
Open	7.62
Previous Close	7.70
Day's Range	7.57 - 7.83
52-Week Range	6.85 - 11.74
Beta	1.44
Analysts	Hold
Price Target	9.20 (+20.26%)
Earnings Date	Nov 6, 2024

About EHAB

Enhabit, Inc. provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer’s disease, low vision, spinal stenosis, Parkinson’s disease, osteoporosis, complex wound care and chronic pain, along with disease-specific p...

• Industry: Medical Care Facilities
• Sector: Healthcare
• Founded: 2014
• Employees: 10,800
• Stock Exchange: NYSE
• Ticker Symbol: EHAB
• Website: https://www.ehab.com

Financial Performance

In 2023, Enhabit's revenue was $1.05 billion, a decrease of -2.32% compared to the previous year's $1.07 billion. Losses were -$80.50 million, 99.3% more than in 2022.

Analyst Forecast

According to 6 analysts, the average rating for EHAB stock is "Hold." The 12-month stock price forecast is $9.2, which is an increase of 20.26% from the latest price.

Price Target

$9.2

(20.26% upside)

Analyst Consensus: Hold